R87.61
Abnormal cytological findings in specimens from cervix uteri
Clinical Classification Guidelines
Excludes Type 1
- abnormal cytological findings in specimens from other female genital organs (R87.69)
- abnormal cytological findings in specimens from vagina (R87.62-)
- carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
- cervical intraepithelial neoplasia I [CIN I] (N87.0)
- cervical intraepithelial neoplasia II [CIN II] (N87.1)
- cervical intraepithelial neoplasia III [CIN III] (D06.-)
- dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
- severe dysplasia of cervix uteri (histologically confirmed) (D06.-)
Excludes Type 2
- cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
- cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)
Medical Intelligence & Overview
The ICD-10 code R87.61 pertains to abnormal cytological findings in specimens collected from the cervix uteri. This diagnosis often arises from screening tests like Pap smears, which examine cervical cells for irregularities. Detecting such abnormalities is crucial for early intervention and prevention of cervical cancer. While an abnormal cytology result can be concerning, it does not necessarily mean cancer is present. Instead, it indicates that further investigation may be necessary to determine the cause of the abnormal cells.
Causes & Symptoms
Clinical Causes: Infections such as human papillomavirus (HPV), herpes simplex virus, or bacterial infections Inflammation or cervical infections Hormonal changes due to pregnancy or menopause Cervical dysplasia, which are precancerous changes in cervical cells Previous radiation therapy or exposure to carcinogens Use of oral contraceptives over a long period of time Smoking
Key Symptoms: Most abnormal cytological findings are asymptomatic and discovered through routine screenings Possible light bleeding or spotting between periods Unusual vaginal discharge Discomfort or pain during sexual intercourse (though less common) No specific symptoms; often identified during routine Pap tests
Diagnostic & Treatment
Diagnosis Path: Diagnosis begins with a Pap smear (Papanicolaou test), a routine screening method where cervical cells are collected and examined under a microscope. If abnormal cells are detected, further testing may be recommended, including: - Colposcopy: a detailed examination of the cervix with a special magnifying device - Biopsy: removal of a small tissue sample for laboratory analysis - HPV testing: to identify high-risk HPV types associated with cervical cancer Additional imaging or procedures might be employed if more severe abnormalities or invasive diseases are suspected.
Treatment Protocols: Management of abnormal cytological findings depends on the specific type and severity of the abnormality, as well as associated risk factors: - Observation: Mild abnormalities may only require periodic monitoring with repeat Pap smears - Surgical intervention: procedures such as cryotherapy, laser therapy, or Loop Electrosurgical Excision Procedure (LEEP) may be used to remove abnormal tissue - Further diagnostic procedures or treatments could be necessary if precancerous or cancerous changes are confirmed As with all medical conditions, treatment plans are personalized based on individual health status and the nature of the cytological findings.
Clinical Advice & FAQs
Billing Guidance
Is R87.61 a billable ICD-10 code?
Yes, R87.61 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R87.61?
Clinical documentation must specify the nature of Abnormal cytological findings in specimens from cervix uteri and any associated comorbidities for accurate reporting.
Cite this Clinical Reference